MYNZ (Mainz Biomed NV) LT-Debt-to-Total-Asset : 0.24 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Mainz Biomed NV's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.24.

Mainz Biomed NV's long-term debt to total assets ratio increased from Mar. 2023 (0.11) to Jun. 2024 (0.24). It may suggest that Mainz Biomed NV is progressively becoming more dependent on debt to grow their business.

Mainz Biomed NV LT-Debt-to-Total-Asset Historical Data

The historical data trend for Mainz Biomed NV's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV LT-Debt-to-Total-Asset Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

3.08

4.03

0.23

0.09

0.14

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial									0.11	0.13	0.13	0.14	0.24

Mainz Biomed NV LT-Debt-to-Total-Asset Calculation

Mainz Biomed NV's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2.196	/	15.409
	=	0.14

Mainz Biomed NV's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	2.027	/	8.454
	=

Mainz Biomed NV (NAS:MYNZ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Mainz Biomed NV LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.